Can you talk about this company?

Stocks Discussed: 
Sinovac Biotech Ltd (SVA)

Submitted by Omar_H. Created on Sunday 20th August 2023. Updated on Sunday 20th August 2023.

Submitted by GrahamValue on Sunday 20th August 2023

Dear Omar_H,

Thank you for your forum post!

Every stock on GrahamValue has an Auto-Generated Summary of its analysis in the Graham Result tab.

On Sinovac Biotech Ltd (SVA), you can see that it says:

Sinovac Biotech Ltd (SVA) clears Graham's qualitative criteria for the NCAV (Net-Net) investment grade. Therefore, its Intrinsic Value is equivalent to its NCAV (Net-Net) Price. As SVA's Intrinsic Value is higher than its Previous Close, its Intrinsic Value(%) evaluates to more than 100% — 1076.98% — and SVA completely clears Graham's criteria for the NCAV (Net-Net) grade.

Thank you again for your forum post!

Submitted by Omar_H on Friday 1st September 2023

Tangible Book Value Per Share (TBVPS):
89.56
quantitative scales

When I looked at quantitative metrics, I think the stock is not worth buying, am I right?

Submitted by GrahamValue on Friday 1st September 2023

Dear Omar_H,

Thank you for your comment!

Sinovac Biotech Ltd (SVA) appears to have a very unusual Earning History, with some very drastic changes in the last few years.

The automated analysis indicates that Sinovac Biotech Ltd (SVA) would be suitable for as an NCAV investment; with not more than 3.3% of one's portfolio per stock.

The stock appears to clear all criteria for Enterprising investment as well, apart from the Dividend requirement.

Being a Health Care stock, it would naturally not qualify for a customized Utilities and Financials analysis either.

Thank you again for your comment!